Who Supplies Melphalan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Melphalan exports, with 153+ registered manufacturers shipping to buyers across 97+ countries — yet a handful of companies dominate the shipments. EMCURE PHARMACEUTICALS LIMITED holds the largest share at 28.9% (export value: $3.7M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LIMITED (8.0%, $1.0M). GLAND PHARMA LIMITED (4.2%, $539.6K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Melphalan? Top Manufacturers & Their Buyers
Flow of Melphalan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Melphalan Supplier Network — Key Market Intelligence
The Melphalan export market from India is led by EMCURE PHARMACEUTICALS LIMITED, which alone commands a 28.9% share, shipping $3.7M worth of product across 221 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LIMITED, contributes $1.0M (8.0%) to the overall market. Combined, the top two suppliers alone account for 36.9% of all Melphalan exports, indicating a relatively concentrated supply base.
Across all 153 tracked manufacturers, the total Melphalan export value stands at $12.8M from 838 shipments. The market average shipment value is $15.2K. The single largest buyer relationship in terms of trade value is TILLOMED LABORATORIES LTD ,,,, receiving $1.1M worth of product.
The combined buyer network spans 16 named purchasing companies, including TILLOMED LABORATORIES LTD ,,,, TILLOMED MALTA LTD, ACE PHARMA CO. LTD., TILLOMED MALTA LIMITED, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the first-largest Melphalan exporter from India, with a market share of 28.9% and a total export value of $3.7M across 221 shipments. Their average shipment value of $16.7K is above the market average of $15.2K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TILLOMED LABORATORIES LTD ,,, — $1.1M across 66 shipments (30.0% of this supplier's total exports)
• TILLOMED LABORATORIES LTD ,,, — $987.5K across 59 shipments (26.8% of this supplier's total exports)
• TILLOMED MALTA LTD — $735.4K across 44 shipments (20.0% of this supplier's total exports)
• ACE PHARMA CO. LTD. — $566.4K across 34 shipments (15.4% of this supplier's total exports)
• TILLOMED MALTA LIMITED — $289.4K across 17 shipments (7.9% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $16.7K is 10% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Melphalan exporter from India, with a market share of 8.0% and a total export value of $1.0M across 22 shipments. Their average shipment value of $46.5K is above the market average of $15.2K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $436.9K across 9 shipments (42.7% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $216.3K across 5 shipments (21.1% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $193.5K across 4 shipments (18.9% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $176.6K across 4 shipments (17.3% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $46.5K is 206% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.
3GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the third-largest Melphalan exporter from India, with a market share of 4.2% and a total export value of $539.6K across 3 shipments. Their average shipment value of $179.9K is above the market average of $15.2K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 3 named buyers in our database. Chris Lessly is the dominant customer, accounting for 88.8% of this supplier's tracked business. Top customers include:
• Chris Lessly — $479.3K across 3 shipments (88.8% of this supplier's total exports)
• XXyazXXiomXXicaXXve — $49.1K across 0 shipments (9.1% of this supplier's total exports)
• XXyazXXiomXXikaXXve — $11.2K across 0 shipments (2.1% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $179.9K is 1082% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.
4EMCURE PHARMACEUTICALS LTD
EMCURE PHARMACEUTICALS LTD is the fourth-largest Melphalan exporter from India, with a market share of 3.5% and a total export value of $441.3K across 15 shipments. Their average shipment value of $29.4K is above the market average of $15.2K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LTD serves 5 named buyers in our database. TILLOMED LABORATORIES LTD ,,, is the dominant customer, accounting for 61.4% of this supplier's tracked business. Top customers include:
• TILLOMED LABORATORIES LTD ,,, — $271.1K across 9 shipments (61.4% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC — $125.4K across 4 shipments (28.4% of this supplier's total exports)
• ARABIAN HEALTH CARE SUPPLY CO. — $22.4K across 1 shipments (5.1% of this supplier's total exports)
• EMCURE PHARMA PERU S — $11.2K across 0 shipments (2.5% of this supplier's total exports)
• EMCURE PHARMA CHILE — $11.2K across 0 shipments (2.5% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LTD's per-shipment value of $29.4K is 93% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.
5INVEX HEALTH PRIVATE LIMITED
INVEX HEALTH PRIVATE LIMITED is the fifth-largest Melphalan exporter from India, with a market share of 1.8% and a total export value of $231.4K across 3 shipments. Their average shipment value of $77.1K is above the market average of $15.2K, suggesting premium or bulk contract pricing.
INVEX HEALTH PRIVATE LIMITED serves 2 named buyers in our database. SENT PHARMA LTD is the dominant customer, accounting for 73.3% of this supplier's tracked business. Top customers include:
• SENT PHARMA LTD — $169.7K across 2 shipments (73.3% of this supplier's total exports)
• SENT PHARMA LIMITED — $61.7K across 1 shipments (26.7% of this supplier's total exports)
Key Insight: INVEX HEALTH PRIVATE LIMITED's per-shipment value of $77.1K is 407% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.
6SP ACCURE LABS PRIVATE LIMITED
SP ACCURE LABS PRIVATE LIMITED is the fifth-largest Melphalan exporter from India, with a market share of 1.5% and a total export value of $192.6K across 30 shipments. Their average shipment value of $6.4K is below the market average of $15.2K, reflecting a high-volume, competitive pricing strategy.
SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. XX RXXDY XXLABXXATOX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XX RXXDY XXLABXXATOX — $192.6K across 30 shipments (100.0% of this supplier's total exports)
Key Insight: SP ACCURE LABS PRIVATE LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Melphalan Flows
Once Melphalan leaves the manufacturing plants of companies like EMCURE PHARMACEUTICALS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED, it travels to 5 destination markets with a combined import value of $12.8M. Russia absorbs the largest share at 23.4% ($3.0M), followed by United Kingdom (21.3%) and Malta (9.5%).
In Russia — the top destination — named importers include FARMAMONDO LLC. In United Kingdom, key buyers are TILLOMED LABORATORIES LTD, TILLOMED LABORATORIES LIMITED, TILLOMED LABORATORIES LTD ,,,.
This geographic spread reflects Melphalan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Melphalan Go? Top Importing Countries & Their Buyers
Trade flow of Melphalan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Melphalan imports from India, with a total trade value of $3.0M across 5 shipments — representing a 23.4% share of all Melphalan exports. The average shipment value of $598.1K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Melphalan importers in Russia: FARMAMONDO LLC is the largest buyer, accounting for 89.6% ($2.7M) of this market's total imports.
• FARMAMONDO LLC — $2.7M (89.6% of Russia's total)
Key Insight: Russia's per-shipment average of $598.1K (3829% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Melphalan imports from India.
2United Kingdom
United Kingdom ranks as the second-largest destination for Melphalan imports from India, with a total trade value of $2.7M across 78 shipments — representing a 21.3% share of all Melphalan exports. The average shipment value of $34.8K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Melphalan importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 57.4% ($1.6M) of this market's total imports.
• TILLOMED LABORATORIES LTD — $1.6M (57.4% of United Kingdom's total)
• TILLOMED LABORATORIES LIMITED — $987.5K (36.4% of United Kingdom's total)
• TILLOMED LABORATORIES LTD ,,, — $166.1K (6.1% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $34.8K (128% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Melphalan imports from India.
3Malta
Malta ranks as the third-largest destination for Melphalan imports from India, with a total trade value of $1.2M across 50 shipments — representing a 9.5% share of all Melphalan exports. The average shipment value of $24.2K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Melphalan importers in Malta: TILLOMED MALTA LTD is the largest buyer, accounting for 60.7% ($735.4K) of this market's total imports.
• TILLOMED MALTA LTD — $735.4K (60.7% of Malta's total)
• TILLOMED MALTA LIMITED — $475.7K (39.3% of Malta's total)
Key Insight: Malta's per-shipment average of $24.2K (59% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Melphalan imports from India.
4Canada
Canada ranks as the fourth-largest destination for Melphalan imports from India, with a total trade value of $978.9K across 5 shipments — representing a 7.7% share of all Melphalan exports. The average shipment value of $195.8K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Melphalan importers in Canada: MARCAN PHARMACEUTICALS INC is the largest buyer, accounting for 41.6% ($406.8K) of this market's total imports.
• MARCAN PHARMACEUTICALS INC — $406.8K (41.6% of Canada's total)
• TARO PHARMACEUTICALS INC. — $193.5K (19.8% of Canada's total)
Key Insight: Canada's per-shipment average of $195.8K (1186% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Melphalan imports from India.
5United States
United States ranks as the fifth-largest destination for Melphalan imports from India, with a total trade value of $968.4K across 0 shipments — representing a 7.6% share of all Melphalan exports. The average shipment value of $968.4K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: United States's per-shipment average of $968.4K (6262% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Melphalan imports from India.
People Also Ask — Melphalan Supplier & Trade Network
Who are the top suppliers of Melphalan from India?+
Which companies buy Melphalan from Indian manufacturers?+
Where does Melphalan exported from India go?+
What is the market share of the top Melphalan supplier from India?+
What is the average shipment value for Melphalan exports from India?+
Is Melphalan manufactured in India and exported globally?+
Which country imports the most Melphalan from India?+
Who are the buyers of Melphalan in United Kingdom?+
How concentrated is the Melphalan supplier market in India?+
How do I find verified buyers for Melphalan in specific countries?+
Melphalan Trade Network — Key Takeaways
- 1EMCURE PHARMACEUTICALS LIMITED is India's dominant Melphalan exporter with a 28.9% market share and $3.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 153 suppliers collectively account for 47.9% of all tracked Melphalan exports, with a combined trade value of $12.8M.
- 3Russia is the largest destination market, absorbing 23.4% of India's Melphalan exports ($3.0M). United Kingdom (21.3%) and Malta (9.5%) follow.
- 4With 838 total shipments averaging $15.2K each, the Melphalan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TILLOMED LABORATORIES LTD ,,,, TILLOMED LABORATORIES LTD ,,,, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 97 countries
Network value: $12.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Melphalan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Melphalan.
- 2.Flow Mapping: 153 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 838 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
838 Verified Shipments
153 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists